Myeloproliferative neoplasms (MPN) arise in hematopoietic stem cells (HSC) through the acquisition of mutations in JAK/STAT signaling pathway genes (JAK2, CALR or MPL), leading to aberrant proliferation of myeloid lineages6. Here, JAK2 is linked to myeloproliferative disorder.